GlassScriptPhysician profile
Bobby O Tackitt
NPI 1386694990
$2,469.51
in general payments reported to CMS, 2019-2025
33 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $194 · 2021: $34.94 · 2022: $653 · 2023: $327 · 2024: $309 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.46 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $444.85 | 2019-2025 | Veozah |
| Abbvie INC. | $328.40 | 2019-2025 | Lo Loestrin Fe |
| Pfizer INC. | $228.10 | 2019-2024 | |
| Boston Scientific Corporation | $147.04 | 2019-2024 | Obtryx System - Curved |
| Evofem Biosciences, INC. | $141.38 | 2022-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $131.89 | 2022-2025 | |
| Medtronic, INC. | $115.41 | 2025 | |
| Myovant Sciences INC. | $105.80 | 2022 | |
| Daiichi Sankyo INC. | $99.55 | 2019-2023 | Injectafer |
| Allergan, INC. | $56.02 | 2019-2020 | |
| Revance Therapeutics, INC. | $55.56 | 2024 | Daxxify |
| Davol INC. | $51.10 | 2019-2025 | Arista |
| Bayer Healthcare Pharmaceuticals INC. | $43.76 | 2023 | |
| Coopersurgical, INC. | $42.13 | 2019-2024 | Wallach Cryosurgical Equipment |
| Novo Nordisk INC | $41.23 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $38.70 | 2024-2025 | Femlyv, Intrarosa |
| Organon LLC | $37.83 | 2024-2025 | Nexplanon |
| Duchesnay USA Incorporated | $35.66 | 2019 | |
| Avion Pharmaceuticals | $35.32 | 2019-2021 | |
| Hologic Sales and Service, LLC | $34.98 | 2019-2025 | Novasure, Myosure Tissue Removal Device |
| Meditrina | $33.39 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $30.39 | 2025 | Myfembree |
| Stryker Corporation | $30.38 | 2020 | |
| Lupin INC. | $24.87 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $19.92 | 2023 | Caldolor |
| Exeltis, USA INC. | $19.23 | 2024 | Slynd |
| Axonics, INC. | $17.47 | 2023 | Bulkamid, Axonics |
| Alexion Pharmaceuticals, INC. | $15.73 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.11 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.04 | 2019 | |
| Ascend Therapeutics US, LLC | $13.20 | 2019 | |
| Therapeuticsmd, INC. | $12.95 | 2019 | |
| Channel Medsystems, INC. | $9.12 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bobby Tackitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.